Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gerlach

Showing results (271-280 of 352) with videos related to

Pageof 36
Sort By:
Diagnostic Microbiology and Infectious Disease|November 1, 1990
Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeaeR N Jones, P C Fuchs, J A Washington, et al.
Cancer Letters|September 29, 1998
Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapyY Canitrot, F Bichat, S P Cole, et al.
Transplantation Proceedings|April 1, 1993
No requirement for cryoprecipitate or platelet transfusion during liver transplantationH Gerlach, R Rossaint, K Slama, et al.
Diagnostic Microbiology and Infectious Disease|April 1, 1986
In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agentsR N Jones, L W Ayers, A L Barry, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility testsR N Jones, A L Barry, C Thornsberry, et al.
The Journal of Biological Chemistry|April 22, 1994
Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive cloneM Moore, X Wang, Y F Lu, et al.
Der Internist|August 31, 2010
[Anticoagulation in the elderly]J Harenberg, R Bauersachs, C Diehm, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteriaP C Fuchs, A L Barry, R N Jones, et al.
The Journal of Trauma|October 23, 1998
Decreased soluble adhesion molecule L-selectin plasma concentrations after major traumaJ C Müller, C Bührer, K L Kiening, et al.
The Journal of Antibiotics|September 1, 1979
Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidisP C Fuchs, C Thornsberry, A L Barry, et al.
Pageof 36

Showing results (271-280 of 352) with videos related to

Sort By:
Pageof 36
Diagnostic Microbiology and Infectious Disease|November 1, 1990
Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeaeR N Jones, P C Fuchs, J A Washington, et al.
Cancer Letters|September 29, 1998
Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapyY Canitrot, F Bichat, S P Cole, et al.
Transplantation Proceedings|April 1, 1993
No requirement for cryoprecipitate or platelet transfusion during liver transplantationH Gerlach, R Rossaint, K Slama, et al.
Diagnostic Microbiology and Infectious Disease|April 1, 1986
In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agentsR N Jones, L W Ayers, A L Barry, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility testsR N Jones, A L Barry, C Thornsberry, et al.
The Journal of Biological Chemistry|April 22, 1994
Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive cloneM Moore, X Wang, Y F Lu, et al.
Der Internist|August 31, 2010
[Anticoagulation in the elderly]J Harenberg, R Bauersachs, C Diehm, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteriaP C Fuchs, A L Barry, R N Jones, et al.
The Journal of Trauma|October 23, 1998
Decreased soluble adhesion molecule L-selectin plasma concentrations after major traumaJ C Müller, C Bührer, K L Kiening, et al.
The Journal of Antibiotics|September 1, 1979
Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidisP C Fuchs, C Thornsberry, A L Barry, et al.
Pageof 36